Information displayed below is a subset of the entire knowledge base and may be incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.
Methaqualone is a sedative-hypnotic drug that was once used to treat insomnia and anxiety. It is a central nervous system depressant and is classified as a Schedule I controlled substance in the United States. It is also known as Quaalude, Sopor, Mandrax, and Parest.
Common side effects of methaqualone include drowsiness, confusion, dizziness, impaired coordination, impaired judgment, and slowed reflexes. Other side effects may include nausea, vomiting, headache, blurred vision, dry mouth, and difficulty urinating. Long-term use of methaqualone can lead to addiction, depression, and memory loss.
All of the following must be considered when interpreting clinical findings
and are too extensive to be covered on this site: